Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2004 Aug;186(16):5538-42.
doi: 10.1128/JB.186.16.5538-5542.2004.

Polymorphic mutation frequencies in Escherichia coli: emergence of weak mutators in clinical isolates

Affiliations

Polymorphic mutation frequencies in Escherichia coli: emergence of weak mutators in clinical isolates

María-Rosario Baquero et al. J Bacteriol. 2004 Aug.

Abstract

Polymorphisms in the rifampin resistance mutation frequency (f) were studied in 696 Escherichia coli strains from Spain, Sweden, and Denmark. Of the 696 strains, 23% were weakly hypermutable (4 x 10(-8) < or = f < 4 x 10(-7)), and 0.7% were strongly hypermutable (f > or = 4 x 10(-7)). Weak mutators were apparently more frequent in southern Europe and in blood isolates (38%) than in urinary tract isolates (25%) and feces of healthy volunteers (11%).

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Distribution of rifampin resistance mutation frequencies of 696 E. coli strains isolated from patients and healthy volunteers from Spain, Sweden, and Denmark. The horizontal arrows show the frequency ranges defining hypomutable strains (H), weakly hypermutable strains (W), and strongly hypermutable strains (S). The peak in the distribution corresponds to the normomutable strains. 1.E-9, 1.0 × 10−9.
FIG. 2.
FIG. 2.
Distribution of rifampin resistance mutation frequencies of 300 Spanish E. coli isolates according to the isolate origin: feces from healthy volunteers (100 isolates) (white bars), urinary tract infections (100 isolates) (shaded bars), and blood cultures (100 isolates) (black bars). 1-4E-9, 1 × 10−9 to 4 × 10−9.
FIG. 3.
FIG. 3.
(a) Distribution of rifampin resistance mutation frequencies of uropathogenic E. coli isolates from 226 Swedish (shaded) and 100 Spanish (black) patients. (b) Distribution of E. coli mutation frequencies of bacteremic isolates from 170 Danish (shaded) and 100 Spanish (black) patients. 1-4E-9, 1 × 10−9 to 4 × 10−9.
FIG. 4.
FIG. 4.
Distribution of normomutable (white), weakly hypermutable (shaded), and strongly hypermutable (black) E. coli strains among isolates inhibited by different ciprofloxacin concentrations. (a) Distribution of the 226 uropathogenic E. coli strains isolated from Swedish patients. (b) Distribution of 75 E. coli strains with an enriched proportion of hypermutable strains isolated from Spanish patients.

References

    1. Cars, O., S. Molstad, and A. Melander. 2001. Variation in antibiotic use in the European Union. Lancet 357:1851-1853. - PubMed
    1. Chao, L., and E. C. Cox. 1983. Competition between high and low mutating strains of Escherichia coli. Evolution 37:125-134. - PubMed
    1. Denamur, E., S. Bonacorsi, A. Giraud, P. Duriez, F. Hilali, C. Amorin, E. Bingen, A. Andremont, B. Picard, F. Taddei, and I. Matic. 2002. High frequency of mutator strains among human uropathogenic Escherichia coli isolates. J. Bacteriol. 184:605-609. - PMC - PubMed
    1. DeVisser, J. A. 2002. The fate of microbial mutators. Microbiology 148:1247-1252. - PubMed
    1. Drake, J. W., B. Charlesworth, D. Charlesworth, and J. F. Crow. 1998. Rates of spontaneous mutation. Genetics 148:1667-1686. - PMC - PubMed

Publication types